Title:
ANTI-CANCER MEDICAMENTS
Document Type and Number:
WIPO Patent Application WO2004060305
Kind Code:
A3
Abstract:
Novel compounds and methods of using those compounds for the treatment of oncological conditions are provided. In a preferred embodiment, modulation of the activation states of abl or bcr-abl a-kinase proteins comprises the step of contacting the kinase proteins with the novel compounds.
Inventors:
FLYNN DANIEL L (US)
PETRILLO PETER A (US)
PETRILLO PETER A (US)
Application Number:
PCT/US2003/041425
Publication Date:
February 10, 2005
Filing Date:
December 26, 2003
Export Citation:
Assignee:
DECIPHERA PHARMACEUTICALS LLC (US)
FLYNN DANIEL L (US)
PETRILLO PETER A (US)
FLYNN DANIEL L (US)
PETRILLO PETER A (US)
International Classes:
A61K31/4152; A61K31/4184; A61K31/433; A61K31/4439; A61K31/444; A61K31/505; A61K31/506; C07D231/14; C07D231/40; C07D239/42; C07D249/12; C07D285/10; C07D295/10; C07D401/04; C07D401/14; C07D403/10; C07D403/12; C07D413/10; C07D413/12; C07D413/14; C07D417/10; C07D417/12; C07D417/14; A61K; (IPC1-7): C07D403/12; C07D413/12; C07D413/14; C07D417/14; A61K31/4152; A61K31/4184; A61K31/433; A61K31/506
Foreign References:
| US6174905B1 | 2001-01-16 | |||
| US6441005B1 | 2002-08-27 |
Other References:
See also references of EP 1590344A4
Download PDF: